STAT

FEBRUARY 11, 2025

Absci and Generate say they use AI to make drugs. Do they?

244

244

Drug Patent Watch

FEBRUARY 11, 2025

The Dark Side of Innovation: How Companies Use Drug Patents to Block Competitors As we celebrate the breakthroughs in medical research and the development of life-saving treatments, it's essential to acknowledge the complex landscape of pharmaceutical innovation. Behind the scenes, companies are employing clever tactics to protect their intellectual property and block competitors from entering the market.

96

96

Express Pharma

FEBRUARY 11, 2025

Roquette, a global provider of plant-based ingredients and pharmaceutical and nutraceutical excipients, has launched its refreshed coatings platform for pharmaceutical and nutraceutical applications. The platform combines two product rangesTabshield ready-to-use film coating systems and ReadiLYCOAT plant-based ready-to-use coating systemsoffering manufacturers a broader selection of coating solutions.

Dosage 85

Dosage 85

STAT

FEBRUARY 11, 2025

KAMPALA, Uganda —  Ebola cases  in Uganda have risen to nine, while 265 other people were being monitored under quarantine, health authorities said Tuesday. The nine include the first victim, a male nurse who died the day before the outbreak was declared on Jan. 30. That man remains the only fatality.

178

178

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

PharmaVoice

FEBRUARY 11, 2025

What will it take for a clinical-stage biotech to break into the cardio space? One CEO thinks he has the answer.

163

163

Express Pharma

FEBRUARY 11, 2025

The Academy of Digital Health Sciences, in collaboration with Bombay College of Pharmacy and the Indian Institute of Management (IIM) Raipur, has launched the Professional Development Programme in Digital Health for Pharmacists. The initiative aims to equip pharmacists with essential digital health skills to enhance pharmaceutical care, streamline workflows, and improve patient outcomes.

66

66

FDA Law Blog: Biosimilars

FEBRUARY 11, 2025

By Alan M. Kirschenbaum & Sophia R. Gaulkin Drug manufacturers wont be receiving their first invoices for Medicare Part B and Part D inflation rebates until later this year, but rebates have been accruing since first quarter 2023 for Part B rebates and October 2022 for Part D rebates. To help our readers learn more about these rebates before they confront the first invoices, weve prepared a memo summarizing CMS final rule on the two Medicare inflation rebate programs, which was issued on De

59

59

Express Pharma

FEBRUARY 11, 2025

Sigachi Industries, has announced a USD 1 million investment to enhance its research and development (R&D) capabilities with the launch of a new R&D centre in Hyderabad. The facility aims to centralise API development and analytical efforts, improving production processes and driving innovation in the sector. The new centre will focus on improving API synthesis, refining the pharma product portfolio, and meeting stringent global regulatory standards.

66

66

PharmaTech

FEBRUARY 11, 2025

Feb. 11, 2025 marks the 10th anniversary of the International Day of Women and Girls in Science.

104

104

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharmaceutical Technology

FEBRUARY 11, 2025

Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront payment of $925m.

102

102

FDA Law Blog: Biosimilars

FEBRUARY 11, 2025

By Larry K. Houck One of the most significant issues facing hospitals and other facilities is the diversion of controlled substances meant for patients by physicians, pharmacists, nurses and other trusted healthcare employees. Recent employee diversion of significant controlled substance quantities from hospitals has resulted in large civil monetary settlements, some in the millions of dollars, and costly compliance remediation programs to resolve allegations.

Controlled Substances 59

Controlled Substances Hospitals 59

Pharmaceutical Technology

FEBRUARY 11, 2025

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease space.

102

102

pharmaphorum

FEBRUARY 11, 2025

Novartis has agreed to buy Anthos from private equity firm Blackstone for $3.1 billion, taking Factor XI inhibitor abelacimab back in-house.

84

84

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Pharma Times

FEBRUARY 11, 2025

New immunotherapy offers hope for recurrent cervical cancer

82

82

Pharmaceutical Technology

FEBRUARY 11, 2025

The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer medicines to LMICs.

Hospitals 80

Hospitals 80

Pharma Times

FEBRUARY 11, 2025

Treatment expands options for HER2-negative metastatic breast cancer

74

74

PhRMA

FEBRUARY 11, 2025

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.

73

73

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

FEBRUARY 11, 2025

It's been 10 years since Roche bought InterMune for $8.3bn on the promise of its pulmonary fibrosis drug Esbriet.

66

66

BioPharma Dive

FEBRUARY 11, 2025

The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed to the Blackstone-backed startup six years ago.

65

65

pharmaphorum

FEBRUARY 11, 2025

Looking beyond the scale: Why measures of physical activity should be incorporated into obesity trials to support long-term sustainable weight loss Mike.

65

65

BioPharma Dive

FEBRUARY 11, 2025

The German drugmaker confirmed acquisition talks, but cautioned a deal may not materialize. Elsewhere, Biohaven got priority review on a key drug and Third Harmonic restructured.

59

59

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

FEBRUARY 11, 2025

Merck KGaA has acknowledged that it is in talks to buy US biotech SpringWorks, but cautioned there is no guarantee a deal will be forthcoming

59

59

PharmaTech

FEBRUARY 11, 2025

Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, discusses the challenges and unmet needs in bringing ADCs to market.

59

59

pharmaphorum

FEBRUARY 11, 2025

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings

59

59

Pharmaceutical Technology

FEBRUARY 11, 2025

The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive approach to AI.

59

59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Commerce

FEBRUARY 11, 2025

Leaders with top third-party logistics providers discuss the evolving landscape for the sector in 2025and the new strides made in their quest to help transform the pharma supply chain.

59

59

Pharmaceutical Technology

FEBRUARY 11, 2025

Grace has announced the initial closing of a financing round, securing almost $15m, for funding pre-commercial development of GTx-104.

59

59

pharmaphorum

FEBRUARY 11, 2025

It's been 10 years since Roche bought InterMune for $8.3bn on the promise of its pulmonary fibrosis drug Esbriet.

59

59